Utilizing Speak Ai’s technology, iSTRYM will provide Ai-driven intelligence to help therapists identify the most efficient and efficacious outcomes for patients of psychedelic assisted psychotherapy VANCOUVER, BC, April 13, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( “MINDCURE” or the “Company”) a leader in advanced proprietary technology for psychedelic therapy…


Previous articleAwakn launches Digital unit and signs agreement with the University of Exeter
Next articlePT239 – Richie Ogulnick – Ibogaine, Unicity, and Beneficence